Format

Send to

Choose Destination
Curr Opin Nephrol Hypertens. 2013 Mar;22(2):193-7. doi: 10.1097/MNH.0b013e32835dcbbe.

Does correction of metabolic acidosis slow chronic kidney disease progression?

Author information

1
Texas A&M College of Medicine, Department of Internal Medicine, Temple, Texas, USA.

Abstract

PURPOSE OF REVIEW:

Most patients with chronic kidney disease (CKD) have progressive decline in glomerular filtration rate (GFR), despite current treatment practices. Recent studies support that dietary acid reduction with oral sodium based alkali or base-inducing food types add kidney protection to that provided by current kidney-protective interventions. Related studies also support that correction of metabolic acidosis with dietary acid reduction slows CKD progression. We reviewed these recent studies that show improvement in CKD parameters and slower CKD progression in response to improvement of CKD-associated metabolic acidosis with these interventions.

RECENT FINDINGS:

Animal as well as human models of CKD show that alkali treatment ameliorates indices of kidney injury and also might slow GFR decline in patients with or without metabolic acidosis. These benefits have been similar with oral sodium-based alkali and base-inducing fruits and vegetables, supporting dietary acid reduction as an effective adjunct to conventional kidney-protective interventions.

SUMMARY:

Recent studies suggest that metabolic acidosis mediates nephropathy progression, and its treatment with the comparatively inexpensive and well tolerated intervention of dietary acid reduction holds promise to be an additional kidney-protective strategy in CKD management.

PMID:
23380803
DOI:
10.1097/MNH.0b013e32835dcbbe
[Indexed for MEDLINE]

Supplemental Content

Full text links

Icon for Wolters Kluwer
Loading ...
Support Center